BIOTECHNOLOGY VALUE FUND L P

10% owner at CTI BIOPHARMA CORP · on record since Jun 28, 2023
10% owner at PALVELLA THERAPEUTICS, INC. · on record since May 22, 2023
Director at Olema Pharmaceuticals, Inc. · on record since Jun 21, 2023
See explanation of responses at Structure Therapeutics Inc. · on record since Feb 13, 2023
Direct Beneficial Owner at AMAG PHARMACEUTICALS, INC. · on record since Jan 13, 2006
10% owner at VIACELL INC · on record since Oct 17, 2007
10% owner at AEOLUS PHARMACEUTICALS, INC. · on record since Feb 13, 2006
See Explanation of Responses at enGene Therapeutics Inc. · on record since Nov 13, 2023
See Explanation of Responses at POINT Biopharma Global Inc. · on record since Nov 6, 2023
Director at Rain Oncology Inc. · on record since Jan 29, 2024
See Remarks; Former 10% Owner at Rain Oncology Inc. · on record since Apr 27, 2021
See Explanation of Responses at Allakos Inc. · on record since Jan 26, 2024
See Explanation of Responses at Xenon Pharmaceuticals Inc. · on record since Sep 12, 2016
See Explanation of Responses at KENT FINANCIAL SERVICES INC · on record since Dec 28, 2011
Direct Beneficial Owner at ADOLOR CORP · on record since Oct 31, 2008
Direct Beneficial Owner at VIACELL INC · on record since Nov 26, 2007
Direct Beneficial Owner at NPS PHARMACEUTICALS INC · on record since Mar 20, 2008
Direct Beneficial Owner at · on record since Jun 26, 2008
Direct Beneficial Owner at · on record since Jun 20, 2008
Direct Beneficial Owner at · on record since May 13, 2008
Director at · on record since Feb 27, 2026
See Explanation of Responses at · on record since Feb 27, 2026
Direct Beneficial Owner at · on record since Nov 26, 2008
Direct Beneficial Owner at · on record since Nov 20, 2008
Direct Beneficial Owner at · on record since Nov 7, 2008
Direct Beneficial Owner at · on record since Apr 29, 2009
Direct Beneficial Owner at · on record since Jun 5, 2009
10% owner at · on record since Jul 11, 2003
10% owner at · on record since Jul 13, 2009
10% owner at · on record since Sep 10, 2009
Direct Beneficial Owner at · on record since Jul 8, 2009
Direct Beneficial Owner at · on record since Jul 17, 2003
10% owner at · on record since Dec 24, 2009
Direct Beneficial Owner at · on record since Jul 22, 2003
See Footnote 1 at · on record since Jul 22, 2003
Direct Beneficial Owner at · on record since Jan 29, 2010
10% owner at · on record since Mar 23, 2011
Director at · on record since Apr 2, 2026
10% owner at · on record since Apr 2, 2026
See Footnote (1) at · on record since Sep 5, 2003
See Explanation of Responses at · on record since Jun 29, 2011
Direct Beneficial Owner at · on record since Apr 22, 2011
See Explanation of Responses at · on record since Oct 14, 2011
See Explanation of Responses at · on record since Sep 9, 2011
See Explanation of Responses at · on record since Oct 7, 2011
Direct Beneficial Owner at · on record since Oct 21, 2003
Direct Beneficial Owner at · on record since Oct 29, 2003
Direct Beneficial Owner at · on record since Nov 7, 2003
10% owner at · on record since Dec 30, 2016
See Explanation of Responses at · on record since Sep 10, 2012
See Explanation of Responses at · on record since Jan 25, 2013
See Explanation of Responses at · on record since May 15, 2013
10% owner at · on record since May 18, 2026
See Explanation of Responses at · on record since Jun 7, 2013
See Footnotes (1)(2) at · on record since Jan 20, 2004
See Explanation of Responses at · on record since Sep 13, 2013
See Explanation of Responses at · on record since Mar 25, 2014
See Footnotes (1) (2) at · on record since Feb 18, 2004
See Explanation of Responses at · on record since Dec 14, 2015
10% owner at · on record since Jun 27, 2016
See Explanation of Responses at · on record since Dec 2, 2016
See Explanation of Responses at · on record since Feb 21, 2017
See Explanation of Responses at · on record since Jun 22, 2017
See Explanation of Responses at · on record since May 11, 2017
10% owner at · on record since Feb 1, 2005
See footnote (1) at · on record since Feb 1, 2005
See Explanation of Responses at · on record since Sep 29, 2017
See Explanation of Responses at · on record since Nov 27, 2017
10% owner at · on record since Oct 20, 2017
See Explanation of Responses at · on record since Dec 8, 2017
See Explanation of Responses at · on record since Nov 26, 2018
See Explanation of Responses at · on record since Nov 9, 2018
See Explanation of Responses at · on record since Jul 1, 2019
See Explanation of Responses at · on record since Oct 31, 2019
10% owner at · on record since Dec 26, 2019
See Explanation of Responses at · on record since Dec 12, 2019
See Explanation of Responses at · on record since Jan 21, 2020
See Explanation of Responses at · on record since Jun 22, 2020
See Explanation of Responses at · on record since Aug 20, 2020
10% owner at · on record since Sep 17, 2020
See Explanation of Responses at · on record since Dec 28, 2020
See Explanation of Responses at · on record since Dec 28, 2020
See Explanation of Responses at · on record since Nov 20, 2020
10% owner at · on record since Nov 19, 2020
10% owner at · on record since Nov 6, 2020
See Explanation of Responses at · on record since Nov 8, 2021
See Explanation of Responses at · on record since Jan 10, 2022
See Explanation of Responses at · on record since Feb 7, 2022
See Explanation of Responses at · on record since Jun 27, 2022
Director at · on record since May 20, 2022
10% owner at · on record since Jun 15, 2022
10% owner at · on record since Jul 21, 2022
Director at · on record since Aug 11, 2022
See Explanation of Responses at · on record since Dec 22, 2022
Director at · on record since Jan 13, 2023
See Remarks and Footnotes at · on record since Aug 25, 2020
10% owner at · on record since Oct 5, 2026

Insider trading activity of BIOTECHNOLOGY VALUE FUND L P

Transactions on record: 301; since Aug 15, 2005

Open-market buys: 166; $83.9M

Open-market sells: 79; $288.3M

Companies traded: 36; last filing Jan 28, 2025

Figures computed from official regulatory filings — .

Companies where BIOTECHNOLOGY VALUE FUND L P has traded

7 tx · $18M · Jan 28, 2025
7 tx · $25.7M · Jun 28, 2024
30 tx · $80.6M · Jun 28, 2023
4 tx · $6.9M · Jun 21, 2023
6 tx · May 12, 2023
3 tx · $8.3M · Jun 3, 2022
6 tx · $9.1M · Jul 6, 2021
3 tx · $24.2M · Jan 26, 2021
5 tx · $3.9M · Dec 22, 2020
6 tx · $153.1M · Nov 13, 2020
9 tx · $20M · May 26, 2020
3 tx · $16.9M · Feb 18, 2020
6 tx · $38.3M · Jun 12, 2019
6 tx · Feb 1, 2019

Track record of BIOTECHNOLOGY VALUE FUND L P

Statistical track record

Free account

Open-market buys: 170

Last buy: Jun 1, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BIOTECHNOLOGY VALUE FUND L P

Co-insiders of BIOTECHNOLOGY VALUE FUND L P

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
XOMA Royalty CorpSecurity delisted	Jan 28, 2025	Sell	-85,776	26.10 USD	$2.2M		SEC
XOMA Royalty CorpSecurity delisted	Jan 28, 2025	Sell	-149,975	26.10 USD	$3.9M		SEC
XOMA Royalty CorpSecurity delisted	Jan 28, 2025	Sell	-339,679	26.10 USD	$8.9M		SEC
XOMA Royalty CorpSecurity delisted	Jan 28, 2025	Sell	-75,287	26.10 USD	$2M		SEC
Kymera Therapeutics, Inc.Listing on record	Jun 28, 2024	AwardD (derivative)	16,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-50,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-3,989,130	9.10 USD	$36.3M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-191	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-17	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-120,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-43,139	9.10 USD	$392.6K	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-2,595,239	9.10 USD	$23.6M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-1,594	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-239	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-344	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-702,505	9.10 USD	$6.4M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-1,526,147	9.10 USD	$13.9M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-12	—	n/a (No price was disclosed in the filing)		SEC
Olema Pharmaceuticals, Inc.Listing on record	Jun 21, 2023	AwardD (derivative)	21,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Structure Therapeutics Inc.Listing on record	May 12, 2023	Other	-2,929,660	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
XOMA Royalty CorpSecurity delisted	Jan 28, 2025	Sell	-85,776	26.10 USD	$2.2M		SEC
XOMA Royalty CorpSecurity delisted	Jan 28, 2025	Sell	-149,975	26.10 USD	$3.9M		SEC
XOMA Royalty CorpSecurity delisted	Jan 28, 2025	Sell	-339,679	26.10 USD	$8.9M		SEC
XOMA Royalty CorpSecurity delisted	Jan 28, 2025	Sell	-75,287	26.10 USD	$2M		SEC
Kymera Therapeutics, Inc.Listing on record	Jun 28, 2024	AwardD (derivative)	16,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-50,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-3,989,130	9.10 USD	$36.3M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-191	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-17	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-120,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-43,139	9.10 USD	$392.6K	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-2,595,239	9.10 USD	$23.6M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-1,594	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-239	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-344	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-702,505	9.10 USD	$6.4M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	Other	-1,526,147	9.10 USD	$13.9M	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 28, 2023	OtherD (derivative)	-12	—	n/a (No price was disclosed in the filing)		SEC
Olema Pharmaceuticals, Inc.Listing on record	Jun 21, 2023	AwardD (derivative)	21,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Structure Therapeutics Inc.Listing on record	May 12, 2023	Other	-2,929,660	—	n/a (No price was disclosed in the filing)		SEC